Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (3100A0-688 107679)
Natural Science Foundation of Zhejiang Province (LR19C050001)
Bundesministerium für Bildung und Forschung (PhosphoNet PPM, Sybacol)
European Research Council (ERC-2008-AdG 233226, ERC-2014-AdG670821)
Foundation for Scientific Research at the University of Zurich
Westlake Startup Grant
Ministère de l'Agriculture, de l'Agroalimentaire et de la Forêt (20190101A04)
SystemsX.ch project PhosphoNet PPM
Received: 28 May 2020
Accepted: 26 October 2020
First Online: 14 December 2020
Ethics approval and consent to participate
: This study was approved by the Cantonal Ethics Committee of Zurich (KEK-ZH-No. 2008-0040), the associated methods were carried out in accordance with the approved guidelines and complied with the Declaration of Helsinki, and each patient has signed an informed consent form.
: Not applicable.
: R.A. holds shares of Biognosys AG, which operates in the field covered by the article. The research groups of R.A. and T.G. are supported by SCIEX, which provides access to prototype instrumentation, and Pressure Biosciences Inc., which provides access to advanced sample preparation instrumentation.